Organizers claimed that nearly 2 million Hong Kong protesters took to the streets Sunday in a rally to demand the city's top official resign a day after she suspended — but...China Politicsread more
Heavy rains caused unprecedented delays in planting this year and contributed to record floods across the central United States.Agricultureread more
Although Cook did not mention companies by name, his commencement speech in Silicon Valley's backyard mentioned data breaches, privacy violations, and even made reference to...Technologyread more
U.S. ambassador to Israel David Friedman called the gesture a "birthday present" to Trump, who turned 73 on Friday.Politicsread more
The agreement, which is on the framework for the plan of adjustment, provide for more than a 60% average haircut for all $35 billion, a 36% haircut on pre-2012 general...Bondsread more
In the survey, 66% of Democratic primary voters say they'd be enthusiastic or comfortable about Biden as their nominee to take on President Trump in the 2020 election. Just...Politicsread more
Target's registers were down on Saturday for several hours preventing customers from checking out.Retailread more
The newspaper wrote that Goldman's executive are hoping CEO David Solomon's changes to a firm that historically thrived in investment banking and trading will boost its...US Marketsread more
The Fed is not likely to make a move on interest rates when it meets next week, but it should clear the way for a rate cut later in the summer.Market Insiderread more
Representatives from the Chinese side say they think it likely that Chinese President Xi Jinping will attend the G-20 meeting later this month. But in order to reach a trade...China Economyread more
With uncertainty keeping a lid on U.S. stocks, Ed Clissold of Ned Davis Research says the rest of 2019 is likely to be a "choppy," but somewhat opportunistic, ride for...Futures Nowread more
CVS Health on Wednesday crushed first-quarter expectations and raised its full-year forecast as the company's newly acquired health insurance business boosted results and its pharmacies filled more expensive prescription drugs.
Its stock price jumped 4%.
Here's what the company reported compared with what Wall Street was expecting, based on average analysts' estimates compiled by Refinitiv:
This was the first full quarter since CVS closed its $70 billion acquisition of health insurer Aetna in November. Revenue for CVS' health-care benefits segment, which also includes CVS' SilverScript business, topped expectations at $17.87 billion.
CVS' retail business also performed better than the Street expected, with same-store sales increasing 3.8%. CVS attributed higher sales in the front of the store to focusing more on health products. In the pharmacy, CVS said selling more expensive branded prescription drugs helped offset more generic drugs and lower payments from insurers.
Drugstores are trying to stay relevant as people shop online more. CVS is testing three stores in Houston called HealthHUBs that include a lab for blood testing and health screenings,wellness rooms for yoga and seminars, dietitians and respiratory specialists.
The concept stores are performing "at or above" CVS' expectations, so the company will expand them and "fill out the Houston market," Merlo said. CVS said it will share more details on its expansion plans at its investor day next month.
CVS and rival Walgreens Boots Alliance have said pressure to lower prescription drug costs is threatening their profits. Companies across the prescription drug supply chain are feeling heat from lawmakers, some of whom are calling to overhaul how drugs are paid for.
A number of Democratic lawmakers and 2020 presidential hopefuls are pushing "Medicare-for-All" proposals that would eliminate private health insurance and replace it with a universal Medicare plan. CVS CEO Larry Merlo on a post-earnings call said recent attention around "access to affordable quality health care" is an "important discussion" and that CVS will continue to be "an active participant" in the debate.
"That said, regardless of what shape and form the next stage of health care takes we remain confident that the private sector will play an essential role in both shaping and executing that next stage," Merlo said. "And importantly we remain best positioned to create and capture new opportunities in this ever-evolving landscape through our local assets our end-to-end health care offerings and our ability to drive engagement positively impacting consumer health."
On an unadjusted basis, CVS' fiscal first-quarter net income rose to $1.42 billion, or $1.09 per share, up from $998 million, or 98 cents per share a year earlier. When excluding the costs of integrating Aetna, store closures and some other items, CVS earned $1.62 per share, above the $1.50 per share expected by analysts surveyed by Refinitiv.
Revenue rose 35% to $61.65 billion — largely driven by the new Aetna business — beating expectations of $60.39 billion.
CVS raised its 2019 earnings forecast to between $6.75 and $6.90 per share, up from the previously guided range of $6.68 to $6.88 per share. Investors punished CVS earlier this year for initially guiding well below the Street's expectations.
"The upward revision of the company's 2019 operating income guidance is encouraging although it comes after the company guided to a significantly lower operating income for 2019 in its fourth quarter earnings call," Moody's Vice President Mickey Chadha said in a statement.